Implantable cardioverter-defibrillators

被引:129
作者
DiMarco, JP [1 ]
机构
[1] Univ Virginia Hlth Syst, Dept Med, Div Cardiovasc, Electrophysiol Lab, Charlottesville, VA 22908 USA
关键词
D O I
10.1056/NEJMra035432
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Implantable cardioverter-defibrillator therapy has been established as an effective method of preventing sudden death from cardiac causes. Few other interventions have been shown as consistently to have equivalent absolute and relative effects on survival among high-risk patients. New models of cardioverter-defibrillators may improve the functional status and quality of life of selected patients who are likely to benefit from biventricular pacing. The implantable defibrillator, however, is invasive and expensive and may expose patients to complications. Optimal use of implantable defibrillators in populations and in individual patients will depend on careful decision making by managers of health care systems, clinicians, and patients.
引用
收藏
页码:1836 / 1847
页数:12
相关论文
共 80 条
  • [1] Cardiac resynchronization in chronic heart failure
    Abraham, WT
    Fisher, WG
    Smith, AL
    Delurgio, DB
    Leon, AR
    Loh, E
    Kocovic, DZ
    Packer, M
    Clavell, AL
    Hayes, DL
    Ellestad, M
    Messenger, J
    Trupp, RJ
    Underwood, J
    Pickering, F
    Truex, C
    McAtee, P
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (24) : 1845 - 1853
  • [2] Resumption of driving after life-threatening ventricular tachyarrhythmia.
    Akiyama, T
    Powell, JL
    Mitchell, LB
    Ehlert, FA
    Baessler, C
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (06) : 391 - 397
  • [3] Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy -: The cardiomyopathy trial (CAT)
    Bänsch, D
    Antz, M
    Boczor, S
    Volkmer, M
    Tebbenjohanns, J
    Seidl, K
    Block, M
    Gietzen, F
    Berger, J
    Kuck, KH
    [J]. CIRCULATION, 2002, 105 (12) : 1453 - 1458
  • [4] Mechanisms of death in the CABG Patch trial - A randomized trial of implantable cardiac defibrillator prophylaxis in patients at high risk of death after coronary artery bypass graft surgery
    Bigger, JT
    Whang, W
    Rottman, JN
    Kleiger, RE
    Gottlieb, CD
    Namerow, PB
    Steinman, RC
    Estes, NAM
    [J]. CIRCULATION, 1999, 99 (11) : 1416 - 1421
  • [5] Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery
    Bigger, JT
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (22) : 1569 - 1575
  • [6] BRISTOW MR, 2003, COMP MED RESYNCHRONI
  • [7] ICD-antiarrhythmic drug and ICD-pacemaker interactions
    Brode, SE
    Schwartzman, D
    Callans, DJ
    Gottlieb, CD
    Marchlinski, FE
    [J]. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 1997, 8 (07) : 830 - 842
  • [8] Prognostic value of baseline electrophysiology studies in patients with sustained ventricular tachyarrhythmia: The Antiarrhythmics Versus Implantable Defibrillators (AVID) trial
    Brodsky, MA
    Mitchell, LB
    Halperin, BD
    Raitt, MH
    Hallstorm, AP
    [J]. AMERICAN HEART JOURNAL, 2002, 144 (03) : 478 - 484
  • [9] Buxton AE, 2000, NEW ENGL J MED, V343, P1813
  • [10] A randomized study of the prevention of sudden death in patients with coronary artery disease
    Buxton, AE
    Lee, KL
    Fisher, JD
    Josephson, ME
    Prystowsky, EN
    Hafley, G
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (25) : 1882 - 1890